TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04504045

Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

Cause of deathSlow enrollment, also staffing, sites or logistics Automatic label, confidence 0.5, unverified. How labels are made.
“Slow recruitment due to COVID-19, the study was stopped when recruited numbers fulfilled the pre-defined lower sample size.”

The sponsor’s own words in the registry.

Life of this trial

2020202120222023Registered2020-07-29Started2020-09-01Stopped2022-05-10

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
University of Southern Denmark
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus, Type 2
Interventions
Metformin; Caffeine; Efavirenz; Losartan; Omeprazol; Metoprolol
Participants
10
Sites
1
Countries
Denmark

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.